TRDA
Entrada Therapeutics, Inc.
-0.05 (-0.73%)6.84USD112K成交股數266M市值–本益比(近四季)56.8股價營收比-54.0%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 898K-96% | 875K-98% | 1.6M-92% | 2.0M-98% | 20.6M-65% | 37.4M-14% | 19.6M+8% | 94.7M+275% | 59.1M | 43.7M | 18.2M | 25.3M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 35.4M | 33.1M | 38.4M | 37.9M | 32.1M | 33.4M | 31.3M | 32.0M | 28.6M | 22.2M | 26.3M | 23.1M |
| 銷售管理費用 | 10.5M | 10.1M | 10.3M | 10.9M | 10.3M | 9.9M | 10.0M | 9.2M | 9.4M | 7.5M | 8.2M | 7.9M |
| 營業利益 | −45.0M+106% | −42.3M+621% | −47.1M+117% | −46.8M-188% | −21.8M-203% | −5.9M-142% | −21.7M+33% | 53.4M-1024% | 21.1M | 14.0M | −16.3M | −5.8M |
| 營業利益率 | -5,007.0% | -4,834.6% | -2,915.2% | -2,402.5% | -106.0% | -15.7% | -110.7% | 56.4% | 35.7% | 32.0% | -89.7% | -22.9% |
| 稅後淨利 | −42.8M+146% | −39.7M-3612% | −44.1M+215% | −43.1M-178% | −17.3M-174% | 1.1M-97% | −14.0M-46% | 55.0M-925% | 23.5M | 35.5M | −25.9M | −6.7M |
| 淨利率 | -4,762.0% | -4,539.1% | -2,734.4% | -2,210.4% | -84.4% | 3.0% | -71.7% | 58.1% | 39.7% | 81.1% | -142.7% | -26.4% |
| 稀釋 EPS | -1.01+140% | -0.95+375% | -1.06+203% | -1.04-167% | -0.42-162% | -0.20-120% | -0.35-55% | 1.55-838% | 0.68 | 1.02 | -0.78 | -0.21 |
| 稀釋股數 | 42.2M | 41.8M | 41.5M | 41.3M | 41.1M | 39.0M | 40.6M | 35.5M | 34.8M | 34.8M | 33.2M | 32.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 99.3M | 76.4M | 93.3M | 72.5M | 67.8M | 101M | 78.0M | 185M | 68.4M | 51.9M | 79.7M | 228M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 299M | 336M | 413M | 449M | 486M | 526M | 555M | 582M | 511M | 485M | 494M | 476M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 65.5M | 64.7M | 72.2M | 69.3M | 69.2M | 97.6M | 132M | 152M | 241M | 238M | 287M | 246M |
| 股東權益 | 233M | 271M | 341M | 380M | 417M | 429M | 422M | 430M | 269M | 247M | 207M | 230M |
| 負債比 | 21.9% | 19.3% | 17.5% | 15.4% | 14.2% | 18.6% | 23.8% | 26.1% | 47.3% | 49.1% | 58.1% | 51.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −41.7M | – | – | −38.5M+51% | – | – | – | −25.5M | – | – | 203M |
| 資本支出 | – | 44K | – | – | 1.1M | – | – | – | 838K | – | – | 1.7M |
| 自由現金流 | – | −41.7M | – | – | −39.7M+50% | – | – | – | −26.4M | – | – | 202M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -4,770.2% | – | – | -192.9% | – | – | – | -44.6% | – | – | 798.6% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 25.4M
| Reportable | 25.4M | 100.0% | -87.9% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 25.4M | -87.9% | −144M | -565.5% | -3.47 | −130M |
| FY2024 | 211M | +63.4% | 65.6M | 31.1% | 1.68 | −44.7M |
| FY2023 | 129M | – | −6.7M | -5.2% | -0.20 | 134M |
| FY2022 | – | – | −94.6M | –% | -3.02 | −96.7M |
| FY2021 | – | – | −51.2M | –% | -8.16 | −55.4M |
| FY2020 | – | – | −26.5M | –% | -24.00 | −27.9M |